pd 142505-0028 has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ewy, W; Hermann, D; Holford, N; Lockwood, P | 1 |
| Amantea, M; Benincosa, LJ; Corrigan, BW; Ewy, W; Glue, P; Hutmacher, MM; Koide, H; Kowalski, KG; Lalonde, RL; Lockwood, PA; Marshall, SA; Miller, R; Milligan, PA; Nichols, DJ; Parivar, K; Tensfeldt, TG | 1 |
| Bowen, DM; Dijk, SN; Francis, PT; Stratmann, GC | 1 |
1 review(s) available for pd 142505-0028 and Alzheimer Disease
| Article | Year |
|---|---|
Model-based drug development.
Topics: Alzheimer Disease; Amines; Analgesics; Animals; Anticholesteremic Agents; Bridged Bicyclo Compounds, Heterocyclic; Caproates; Cholesterol; Clinical Trials as Topic; Cognition; Computer Simulation; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Approval; Drug Design; Gabapentin; gamma-Aminobutyric Acid; Glycoproteins; Guidelines as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunologic Factors; Meta-Analysis as Topic; Models, Biological; Models, Statistical; Muscarinic Agonists; Neuralgia, Postherpetic; Neutrophil Infiltration; Oximes; Pharmacokinetics; Pharmacology; Reproducibility of Results; Research Design; Stroke; United States; United States Food and Drug Administration | 2007 |
1 trial(s) available for pd 142505-0028 and Alzheimer Disease
| Article | Year |
|---|---|
Application of clinical trial simulation to compare proof-of-concept study designs for drugs with a slow onset of effect; an example in Alzheimer's disease.
Topics: Algorithms; Alzheimer Disease; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Cognition Disorders; Computer Simulation; Cross-Over Studies; Dose-Response Relationship, Drug; Half-Life; Humans; Models, Statistical; Nootropic Agents; Oximes; Placebos; Population; Research Design | 2006 |
1 other study(ies) available for pd 142505-0028 and Alzheimer Disease
| Article | Year |
|---|---|
Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: implications for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Cholinergic Agents; Corpus Striatum; Glutamic Acid; Male; Neural Pathways; Neurons; Oximes; Physostigmine; Rats; Rats, Sprague-Dawley | 1995 |